Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy

BACKGROUND. Treatment of splenic marginal zone lymphoma (SMZL) patients is not standardized. Recent data suggest that rituximab is highly effective and could be considered as initial therapy. AIM. To assess the efficacy of rituximab monotherapy in a large series of patients with SMZL and compare the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kalpadakis, Christina, Pangalis, Gerassimos A., Angelopoulou, Maria K., Sachanas, Sotirios, Kontopidou, Flora N., Yiakoumis, Xanthi, Kokoris, Stella I., Dimitriadou, Evagelia M., Dimopoulou, Maria N., Moschogiannis, Maria, Korkolopoulou, Penelope, Kyrtsonis, Marie-Christine, Siakantaris, Marina P., Papadaki, Theodora, Tsaftaridis, Panayiotis, Plata, Eleni, Papadaki, Helen E., Vassilakopoulos, Theodoros P.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Lymphoma
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579603/
https://ncbi.nlm.nih.gov/pubmed/23345547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0251
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados